KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Curent Deferred Tax Liability Current Assets Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Teva Pharmaceutical Industries (TEVA) Pension (2016 - 2017)

Historic Pension for Teva Pharmaceutical Industries (TEVA) over the last 5 years, with Q3 2017 value amounting to $718.0 million.

Teva Pharmaceutical Industries' Pension changed N/A to $718.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $718.0 million, marking a year-over-year change of. This contributed to the annual value of $859.0 million for FY2016, which is N/A changed from last year.
Latest data reveals that Teva Pharmaceutical Industries reported Pension of $718.0 million as of Q3 2017.
Over the past 5 years, Teva Pharmaceutical Industries' Pension peaked at $859.0 million during Q4 2016, and registered a low of $660.0 million during Q1 2017.